Systemic Evaluation of Anti-diabetics, Anti-Inflammatory and Secondary Metabolite Potentials of Aframomum melegueta [Roscoe] K.
South Asian Journal of Parasitology,
This research work helps to investigate systemic evaluation of anti-diabetics,, anti-Inflammatory and Secondary metabolite potential of stem, leaf-sheath, Fruit-pulp and seed Extracts of Aframomum melegueta. Diabetes mellitus is characterized as metabolic disorders which increases glucose levels (hyperglycemia) of blood, due to failings in insulin secretion and related resistance to its actions. Fresh plant samples of Aframomum melegueta were harvested from the reserved forest of Akungba Akoko Ondo State (Nigeria) on February 4th, 2020 early in the morning. Dried and pulverized samples were extracted by cold ethanol maceration method for 48 hours. The medicinal potentials were determined using Kim”s and Demoraes, Leelaprakash”s and Perry”s, Priya”s and Babu’s method of analysis. The leaf-sheath has the highest inhibition percentage for α-glucosidase (79.58%) in this study while the stem has the lowest inhibition (25.60%) percentages. In all the parameter investigated, the seed extract has the highest inhibition percentage (46.21%, 33.25%, 45.11% and 39.84%) while Stem has the lowest percentage (8.23, 21.01, 22.18, and 20.52%). It is definite that the seed has the largest percentage concentration of Anti-Inflammatory potentials in Aframomum melegueta (Heat induced haemolysis, Antiproteinase, Hypotonicity-induced haemolysis, and Inhibition of albumin denaturation). The most prominent components observed in Aframomum melegueta were Flavonoids, Terpenoids and Cardiac glycosides while fewer components present were Anthocyanin and Beta cyanin. This research work supports herbal usage of Aframomum melegueta to reduce the menace of diabetics, inflammatory activity of malignant cells caused by diabetes mellitus in human system and in formulation of synthetic drug the plant supplements for therapeutic purposes.
- Systemic evaluation
- secondary metabolite Aframomum melegueta
How to Cite
Vijan S. Type 2 diabetes. Ann. Intern. Med. 2010;152:ITC3-1.
Miranda-Díaz AG, Pazarín-Villaseñor L, Yanowsky-Escatell FG, Andrade-Sierra J. Oxidative stress in diabetic nephropathy with early chronic kidney disease. J. Diabetes Res; 2016.
Atkinson MA, Eisenbarth GS, Michels AW. Type 1 diabetes. Lancet. 2014;383:69-82.
Althunibat OY, Al Hroob AM, Abukhalil MH, Germoush MO, Bin-Jumah M, Mahmoud AM. Fisetin ameliorates oxidative stress, inflammation and apoptosis in diabetic car diomyopathy. Life Sci. 2019;221:83–92.
Osuntokun OT, Oluduro AO, Idowu TO, Omotuyi AO. Assessment of nephrotoxicity, anti-inflammatory and antioxidant properties of epigallocatechin, epica techin and stigmasterol phytosterol (synergy) derived from ethyl acetate stem bark extract of Spondias mombin on wister rats using molecular method of analysis. Journal of Molecular Microbiology. 2017;1 (1):103:1-11.
Zhang H, Sun SC, NF B. In inflammation and renal diseases. Cell Biosci. 2015;5:63.
Liu T, Zhang L, Joo D, Sun SC, NF B. Signaling in inflammation, signal transduct target. Ther. 2017;2:17023.
Mano Y, Anzai T, Kaneko H, Nagatomo Y, Nagai T, Anzai A, Maekawa Y, Takahashi T, Meguro T, Yoshikawa T. Overexpression of human C-reactive protein exacerbates left ventricular remodeling in diabetic cardiomyopathy. Circ. J. 2011; 75:1717–1727.
Yu XY, Chen HM, Liang JL, Lin QX, Tan HH, Fu YH, Liu XY, Shan ZX, Li XH, Yang HZ. Hyperglycemic myocardial damage is mediated by proinflammatory cytokine: Macrophage migration inhibitory factor. Plos One. 2011;6:e16239.
Fuentes-Antrás J, Ioan AM, Tuñón J, Egido J, Lorenzo Ó. Activation of toll-like receptors and inflamma some complexes in the diabetic cardiomyopathy-associated inflammation. Int. J. Endocrinol. 2014; 1–10.
Goldin A, Beckman JA, Schmidt AM, Creager MA. Advanced glycation end products. Circulation. 2006;114:597–605.
Nishida K, Otsu K. Inflammation and metabolic cardiomyopathy. Cardiovasc. Res. 2017;113: 389–398.
Osuntokun OT, Olumekun VO, AjayiA O, Omotuyi IO, Olonisakin A. Assessment of In-vitro antioxidant/enzymes inhibitory potentials of Aframomum melegueta [Roscoe] K. Schum (grains of paradise) leaf, stem bark, seed bark and seed extracts. Archives of Current Research International 2020;20(2):40-57.
Article no.ACRI.55957 ISSN: 2454-7077.
Mohammeda A, Gbonjubola VA, Koorbanallyc NA, Islama MS. Inhibition of key enzymes linked to type 2 diabetes by compounds isolated from Aframomum melegueta fruit. Pharmaceutical Biology. 2017;55(1):1010-1016.
Kim YM, Jeong YK, Wang MH, Lee WY, Rhee HI. Inhibitory effect of pine extract on α-glucosidase activity and postprandial hyperglycemia. Nutrition. 2005;21(6): 756–761.
Leelaprakash G, Mohan Dass S. International Journal of Drug Development & Research. 2011; 3(3).
De Moraes LMP, Filho SA, Ulhoa CJ. Purification and some properties of an -amylase glucoamylase fusion protein from Saccharomyces cerevisiae. World J. Microbiol. Biotech. 1999;15: 561-564.
Perry NS, Houghton PJ, Theobald A, Jenner P, Perry EK. In-vitro inhibition of human erythrocyte acetylcholinesterase by Salvia lavandulaefolia essential oil and constit uent terpenes. J. Pharm. Pharmacol. 2000;52(7):895-902.
Boulekbache-Makhlouf L, Slimani S, Madani K. Antioxidant effects and phyto chemical analysis of crude and chromatographic fractions obtained from Eucalyptus globulus bark. African J Biotech. 2012;11(42):10048-55.
Priya G, Chellaram C. Evaluation of antibacterial activity and phytochemical analysis of medicinal plant Solanum trilobatum. Int J Pharm Bio Sci. 2014;5(3): 354-9.
Babu K, Samundeeswari A, Chitti Babu CV. Studies on phytochemical screening, estimation of tannin and antioxidant activity of Delonix elata Lind. Int J Curr Sci. 2015;15S:E37-42.
Sahaya SS, Janakiraman N, Johnson M. Phytochemical analysis of Vitex altissima L. using UV-VIS, FTIR and GC-MS. Int J Pharm Sci Drug Res. 2017;4(1):56-62.
Osuntokun OT, Ajayi A, Adeoye MI, Odufunwa AE. Assessment of anti microbial and phytochemical properties of crude leaf and bark extracts of Ceiba Pentandra on selected clinical isolates found in nigerian teaching hospital. Journal of Bacteriology & Mycology. 2017; 4(1):00079.
DOI :10.15406/jbmoa.20 17.04.00079
Du WQ, ShiX F, Qiu MY. Progress in treatment of diabetes drugs Chin. Hosp. Pharm. J. 2005;25:67-69.
Sofowora A. Medicinal plants and traditional medicine in Africa. 5th Edition. Spectrum book limited Ibadan, Nigeria. 2006;289.
Playford RJ, Pither C, Gao R. Use of the α-glucosidase inhibitor acarbose in patients with ‘Middleton syndrome’: Normal gastric anatomy but with accelerated gastric emptying causing postprandial reactive hypoglycemia and diarrhea. Can. J. Gastroenterol. 2013;27:403-404.
Abhijit S, Rashmi S, Srivastava Nikita S, Yashwant M, Bhagyashri C. Anti-diabetic activity of Tridax procumbens. J Sci Innovative Res. 2014;3(2):221-6.
Raman BV, Naga Vamsi Krishna A, Narasimha Rao B, Pardha Saradhi M, Basaveswara Rao MV. Plants with antidiabetic activities and their medicinal values. Int Res J Pharm. 2012;3(3):11-5.
Amin MM, Sawhney SS, Jassal MMS. In-vitro antidiabetic studies of various extracts of Taraxacum officinale. Pharm Innov J. 2015;4(1):61-6.
Anuradha Devi V, Mallikarjuna K. In-vitro antimicrobial and antidiabetic activity of leaf extracts of Schrebera swietenioides and Homalium zeylanicum. Int J Life Sci Pharma Res. 2016;6(3):1-7.
Mbaze LM, Poumale HMP, Wansi JD. α-Glucosidase inhibitory pentacyclic triterpenes from the stem bark of Fagara tessmannii (Rutaceae). Phyto chemistry. 2007;68:591-595.
Gerard J Tortora, Sandra Reynolds, Eds. Principles of anatomy and physiology. Harper Collins College Publishers, 7th edition. 1993;695.
Shenoy S, Shwetha K, Prabhu K, Maradi R, Bairy KL, Shanbhag T. Evaluation of anti-inflammatory activity of Tephrosia purpurea in rats. Asian Pac J Rop Med. 2010;3(3):193-5.
Mizushima Y, Kobayashi M. Interaction of antiinflammatory drugs with serum preoteins, specially with some biologically active proteins. J of Pharma Pharmacol. 1968;20:169:173.
Osadebe PO, Omeje EO, Uzor PF, David EK, Obiorah DC. Seasonal variation for the antidiabetic activity of Loranthus micranthus methanol extract. Asian Pac J Trop Med. 2010;3(3):196-9.
Poongunra J, Pere HKI, Fernando WIT, Jayasinghe L, Sivakanesan R. α- Glucosidase and α-amylase inhibitory activities of nine Sri Lankan anti diabetic plants. British J Pharm Res. 2015;7(5): 365-74.
Vinodhini V, Himaja M, Sai S, Poppy D. In-vitro antidiabetic activity of Tragia involucrata Linn. Leaf extracts. Int J Res Ayurveda Pharm. 2015;6(1):1-3.
Khan MF, Rawat AK, Pawar B, Gautam S, Srivastava AK, Negi DS. Bioactivity guided chemical analysis of Melia azedarach L. (Maliaceae), displaying antidiabetic activity. Fitoterapia. 2014;98:98-103.
Guevarra BQ. A guidebook to plant screening phytochemical and biological. UST Publishing House, Philippines. Hawkins EB, Ehrich SD, Goto Kola Editiors University of Maryland Medical Center, Baltimore, USA; 2005.
Osuntokun OT, Yusuf-Babatunde MA, Oladele OF. Components and bioactivity of Ipomoea batatas (L.) (Sweet Potato) ethanolic leaf extract. Asian Journal of Advanced Research and Reports. 2020;10(1):10-26
Article no. AJARR.56421, ISSN:2582-3248
Abstract View: 54 times
PDF Download: 21 times